FDA Gathers Feedback To Guide Oversight Of Lab-Developed Testing
This article was originally published in The Gray Sheet
Executive Summary
FDA says it will tailor its future oversight of laboratory tests and services based on risk, but experts warn that "high risk" will be hard to define for these diagnostics